July 18, 2024
Via: Drugs.comYou’re far less likely to develop Long COVID now than you were in the midst of the pandemic, promising new data shows. Changes in strains of SARS-CoV-2, the virus that causes COVID-19, are playing a role in the lowered risk, […]
July 4, 2024
Via: PharmaphorumThe award from the Biomedical Advanced Research and Development Authority (BARDA) will be used to accelerate the development of pandemic flu vaccines, according to Moderna, and specifically “support late-stage development for an mRNA-based vaccine to enable the licensure of a […]
FDA, Industry, Regulations, Vaccines
June 14, 2024
Via: Drugs.comCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot of the JN.1 variant that spread widely last winter, the U.S. Food and Drug Administration announced Thursday. It’s a turnaround for the agency: […]
FDA, Industry, Regulations, Vaccines
June 10, 2024
Via: Drugs.comThe U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness. Drugmaker GSK’s Arexvy vaccine, […]
FDA, Industry, Regulations, Vaccines
June 6, 2024
Via: Biopharma DiveA group of advisers to the Food and Drug Administration on Wednesday unanimously recommended that COVID-19 vaccines be updated to cover coronavirus strains with a family known as JN.1 ahead of the fall. The committee, which had originally been scheduled […]
June 3, 2024
Via: Drugs.comAs the H5N1 avian flu continues to spread among dairy cows in the United States, nearly 5 million doses of flu vaccine are now being prepared for possible use in humans. Since the outbreak in livestock began this spring, bird […]
FDA, Industry, Regulations, Vaccines
May 31, 2024
Via: Biopharma DiveThe Food and Drug Administration on Friday approved a third vaccine for respiratory syncytial virus, clearing a shot from biotechnology company Moderna one year after granting a green light to vaccines from GSK and Pfizer. The vaccine, dubbed mResvia, is […]
May 29, 2024
Via: Drugs.comHumanity’s best protection against bird flu will be the development of effective vaccines, a new study says. The H5N1 avian flu has been raging through cattle and poultry in the United States, increasing fears that the virus will make the […]
May 21, 2024
Via: Drugs.comPowerful COVID vaccines could be setting people’s immune systems up to successfully fight off not just future COVID variants, but other types of coronaviruses as well, a new study shows. People repeatedly vaccinated for COVID — the initial shots, followed […]
FDA, Industry, Regulations, Vaccines
May 13, 2024
Via: PharmaphorumThe company said the FDA would not be able to complete its review of the mRNA-1345 vaccine by the scheduled date of 12th May due to “administrative constraints”, causing nervousness among investors that led to a near-3% decline in its […]
Industry, Mergers and Acquisitions, Vaccines
May 10, 2024
Via: Biopharma DiveAllying with Sanofi is a boost for Novavax, which has seen its share price crumble and come under activist investor pressure as it struggles to sell its COVID shot. The company pitched the vaccine as an alternative to the dominant […]
April 30, 2024
Via: Drugs.comKids who don’t like vaccination shots might soon have an alternative in a painless skin patch, researchers say. More than 90% of 190 Gambian infants were protected from measles and all were protected from rubella after receiving a single vaccine […]
April 29, 2024
Via: Drugs.comGlobal vaccination efforts have saved an estimated 154 million lives, including 101 million infants, a new study led by the World Health Organization (WHO) shows. Immunization has contributed more to the health and survival of newborns than any other medical […]
Industry, Mergers and Acquisitions, Vaccines
April 19, 2024
Via: Pharma TimesCureVac and the University of Texas’s MD Anderson Cancer Center have announced a co-development and licensing agreement to develop novel messenger ribonucleic acid (mRNA)-based cancer vaccines. The strategic collaboration will focus on the development of differentiated cancer vaccine candidates in […]
April 18, 2024
Via: Kaiser Health NewsA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other. The BCG (Bacille Calmette-Guérin) vaccine, created in 1921, remains […]
Clinical Trials, Industry, Research and Development, Vaccines
April 10, 2024
Via: PMLiVERSV is a common contagious virus characterised by several mild, cold-like symptoms. Although most people recover within a week or two, the virus can cause severe illness in certain groups, including older adults, infants and those with certain underlying chronic […]
Industry, Mergers and Acquisitions, Vaccines
April 3, 2024
Via: Biopharm InternationalOn Mar. 25, 2024 Univercells announced a collaboration with Altamira Therapeutics, a producer of nanoparticle-based technology, under which Univercells will use Altamira’s SemaPhore nanoparticle platform to deliver messenger RNA (mRNA) vaccines. Also on Mar. 25, Andelyn Biosciences, a contract development […]
FDA, Industry, Regulations, Vaccines
March 4, 2024
Via: Drugs.comAs new outbreaks of measles — a once nearly eliminated illness in the United States — continue to emerge, experts remind Americans that there’s an easy way to stop infection: Get vaccinated. “Measles spreads so easily that if one person […]
February 8, 2024
Via: Drugs.comA doctor or nurse might be the only person capable of convincing a vaccine-hesitant person to get the COVID jab, a new study shows. Those who trust the medical profession are most likely to get vaccinated against COVID, despite their […]
February 6, 2024
Via: Drugs.comWhen getting vaccines, switching arms for each dose may produce greater immunity than having the jabs delivered into the same arm. That’s the finding from a new study that looked at the first two doses of COVID vaccines. Those who […]